-
16
-
-
0029623184
-
Computational methods to predict binding free energy in ligand-receptor complexes
-
(1995)
J. Med. Chem.
, vol.38
, pp. 4953-4967
-
-
Ajay1
Murcko, M.A.2
-
18
-
-
0028158936
-
Ligand docking to proteins with discrete side-chain flexibility
-
(1994)
J. Mol. Biol.
, vol.235
, pp. 345-356
-
-
Leach, A.R.1
-
21
-
-
0000008625
-
Free energy calculations: Methods and applications
-
Encyclopedia of Computational Chemistry; Schleyer, P. V. R., Allinger, N. L., Clark, T., Gasteiger, J., Kollman, P. A., Schaefer, H. F., III, Schreiner, R. P., Eds.; John Wiley & Sons: New York
-
(1998)
, pp. 1036-1061
-
-
Pearlman, D.A.1
Rao, B.G.2
-
23
-
-
0032698313
-
Free energy grids: A practical qualitative application of free energy perturbation to ligand design using the OWFEG method
-
(1999)
J. Med. Chem.
, vol.42
, pp. 4313-4324
-
-
Pearlman, D.A.1
-
24
-
-
0029899127
-
Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid
-
(1996)
Cell
, vol.85
, pp. 921-930
-
-
Sintchak, M.D.1
Fleming, M.A.2
Futer, O.3
Raybuck, S.A.4
Chambers, S.P.5
Caron, P.R.6
Murcko, M.A.7
Wilson, K.P.8
-
25
-
-
15844389292
-
Inhibition of IMPDH by mycophenolic acid: Dissection of forward and reverse pathways using capillary electrophoresis
-
(1996)
Biochemistry
, vol.35
, pp. 6990-6997
-
-
Fleming, M.A.1
Chambers, S.P.2
Connelly, P.R.3
Nimmesgern, E.4
Fox, T.5
Bruzzese, F.J.6
Hoe, S.T.7
Fulghum, J.R.8
Livingson, D.J.9
Stuver, C.M.10
Sintchak, M.D.11
Wilson, K.P.12
Thomson, J.A.13
-
26
-
-
0032535314
-
Design and synthesis of novel conformationally restricted HIV protease inhibitors
-
(1998)
Bioorg. Med. Chem. Lett.
, vol.8
, pp. 3637-3642
-
-
Salituro, F.G.1
Baker, C.T.2
Court, J.J.3
Deininger, D.D.4
Li, B.5
Novak, P.M.6
Rao, B.G.7
Pazhanisamy, S.8
Porter, M.D.9
Schairer, W.C.10
Tung, R.D.11
-
27
-
-
0032534853
-
Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitors
-
(1998)
Bioorg. Med. Chem.
, vol.8
, pp. 3631-3636
-
-
Baker, C.T.1
Salituro, F.G.2
Court, J.J.3
Deininger, D.D.4
Kim, E.E.5
Li, B.6
Novak, P.M.7
Rao, B.G.8
Pazhanisamy, S.9
Schairer, W.C.10
Tung, R.11
-
28
-
-
0028846226
-
Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme
-
(1995)
J. Am. Chem. Soc.
, vol.117
, pp. 1181-1182
-
-
Kim, E.E.1
Baker, C.T.2
Dwyer, M.D.3
Murcko, M.A.4
Rao, B.G.5
Tung, R.D.6
Navia, M.A.7
-
29
-
-
12644277392
-
The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase
-
(1997)
Chem. Biol.
, vol.4
, pp. 423-431
-
-
Wilson, K.P.1
McCaffrey, P.G.2
Hsiao, K.3
Pazhanisamy, S.4
Galullo, V.5
Bemis, G.W.6
Fitzgibbon, M.J.7
Caron, P.R.8
Murcko, M.A.9
Su, M.S.10
-
36
-
-
0003700434
-
-
University of California: San Francisco
-
(1997)
AMBER 5.0
-
-
Case, D.A.1
Pearlman, D.A.2
Caldwell, J.C.3
Cheatham III, T.E.4
Ross, W.S.5
Simmerling, C.6
Darden, T.7
Merz, K.M.8
Stanton, R.V.9
Cheng, A.10
Vincent, J.J.11
Crowley, M.12
Ferguson, D.M.13
Radmer, R.14
Seibel, G.L.15
Singh, U.C.16
Weiner, P.17
Kollman, P.A.18
-
39
-
-
0006150210
-
-
Vertex Pharmaceuticals Inc., Cambridge MA
-
-
-
-
40
-
-
0029063951
-
A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site
-
(1995)
J. Med. Chem.
, vol.38
, pp. 305-317
-
-
Holloway, M.K.1
Wai, J.M.2
Halgren, T.A.3
Fitzgerald, P.M.D.4
Vacca, J.P.5
Dorsey, B.D.6
Levin, R.B.7
Thompson, W.J.8
Chen, L.J.9
Desolms, S.J.10
Gaffin, N.11
Ghosh, A.K.12
Giuliani, E.A.13
Graham, S.L.14
Guare, J.P.15
Hungate, R.W.16
Lyle, T.A.17
Sanders, W.M.18
Tucker, T.J.19
Wiggins, M.20
Wiscount, C.M.21
Woltersdorf, O.W.22
Young, S.D.23
Darke, P.L.24
Zugay, J.A.25
more..
|